View Article

Abstract

The groundbreaking TEMPO 3:4 trial, which served as the basis for tolvaptan's approval, represented a revolution in the treatment of autosomal dominant polycystic kidney disease (ADPKD). Through this advancement, patient management for ADPKD has evolved from using broad strategies to stop the progression of chronic kidney disease to focusing on disease-specific mechanisms. Evidence-based strategies to start treatment only in patients with quickly worsening disease are essential, though, given the long-term nature of this medication and associated side effects. The European Renal Association (ERA) policy statement, released in 2016, was the first society-based guideline on the usage of tolvaptan and has been a popular resource for nephrologists when making decisions. Since then, there has been a significant accumulation of practical knowledge regarding the use of tolvaptan in ADPKD.

Keywords

ADPKD; polycystic kidney disease; position statement; tolvaptan; vasopressin V2 receptor antagonist

Reference

  1. Zilberberg MD, Exuzides A, Spalding J, et al. Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin. 2008;24(6):1601–1608.
  2. Verbalis JG, Goldsmith SR, Greenberg A, et al. Hyponatremia treatment guidelines 2007: Expert panel recommendations. Am J Med. 2007;120(11A):S1–S21. 
  3. Rockville, MD: Otsuka America Pharmaceutical, Inc.; May 2009. Samsca (tolvaptan), package insert. 
  4. Schrier RW, Gross P, Gheorghiade M, et al.for the SALT Investigators Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355:2099–2112.
  5. Gheorghiade M, Konstam MA, Burnett JC, et al.for the EVEREST Investigators Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST Clinical Status Trials. JAMA. 2007;297:1332–1343.
  6. Konstam MA, Gheorghiade M, Burnett JC, et al.for the EVEREST Investigators Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial. JAMA. 2007;297:1319–1331.
  7. Schrier RW, Gross P, Gheorghiade M, et al.for the SALT Investigators Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355:2099–2112. 
  8. Gheorghiade M, Konstam MA, Burnett JC, et al.for the EVEREST Investigators Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST Clinical Status Trials. JAMA. 2007;297:1332–1343
  9. Konstam MA, Gheorghiade M, Burnett JC, et al.for the EVEREST Investigators Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial. JAMA. 2007;297:1319–1331.
  10. Structure of Tolvaptan - https://web.chemdoodle.com/demos/iupac-naming#customise-template
  11. Indian Pharmacopoeia - 2022,  Ninth Edition, Volume – III, Page number: 3832, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Chowdavaram, Guntur, Andhra Pradesh, India.

Photo
Kondeti Venkata Surya Siva Kumar
Corresponding author

Department of Pharmacology and Pharmaceutics, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Chandramoulipuram, Chowdavaram, Guntur, Andhra Pradesh – 522019, India

Photo
Saripella Latha Sree
Co-author

Department of Pharmacology and Pharmaceutics, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Chandramoulipuram, Chowdavaram, Guntur, Andhra Pradesh – 522019, India

Photo
Saripella Jaya Sree
Co-author

Department of Pharmacology and Pharmaceutics, Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Chandramoulipuram, Chowdavaram, Guntur, Andhra Pradesh – 522019, India

Kondeti Venkata Surya Siva Kumar, Saripella Latha Sree and Saripella Jaya Sree, Tolvaptan - Vasopressin Antagonist for Hyponatremia, Int. J. in Pharm. Sci., 2023, Vol 1, Issue 8, 1-8. https://doi.org/10.5281/zenodo.8206257

More related articles
Emerging Technologies: Application Of Artificial I...
Atharva Dumbre , Saurabh Dushing , Shejal Dongare , Sanjana Gadek...
Menstrual health: An Herbal Tea Approach...
Dr. Shivam Lale, Vaishnavi Muthal, Harshal Shewale, Nikita Nagare...
Ashwagandha (Withania somnifera), Taxonomy, Pharma...
Yash Srivastav , Samsher Bahadur Bind, Aditya Srivastav, ...
Quality Risk Management: A Current International Pharmaceutical Industry Practic...
Dr. Gurmeet Chhabra, Gourav Kushwah, Dr. Nimita Manocha, Gaurav Sarsodia , ...
Preparation And Evaluation of Kalanchoe Pinnata Herbal Tea for Kidney Stone Trea...
Buddharatna Dongre , Karan Sukalkar , Akshay Brokar , Dr. Akshit Naveriya , ...
Oral Delivery Challenges & Formulation Strategies for Glucagon Like Peptide-1 Re...
Patil Rajvardhan, Patil Snehit , Kadam Swapnil , Sulgudle Shivraj , Dr. Gejage Santosh , ...
Related Articles
Formulation And Evaluation of Watermelon Seeds Loaded Spherules as Nutraceutical...
Vishal Raparla, Nitin Padole, Pankaj Dhapke, Jagdish Baheti, ...
Quality By Design: A Concise Review In Pharmaceutical Sciences...
Netra Machhindra Adhav , Dr.Rishikesh.S. Bachhav, Shubhangi Vishwanath Bhalerao , ...
Polymyxin B Dosing in Renal Impairment Once-Daily Versus Twice-Daily Regimens: A...
Dr. Vadapalli Rama Rao, Adithya Shetty H, Mohammed Sonia, Dr. Manoj D.V, Prateeksha Vinnu, Adnan Sha...
Emerging Technologies: Application Of Artificial Intelligence and Machine Learni...
Atharva Dumbre , Saurabh Dushing , Shejal Dongare , Sanjana Gadekar, Rina Gaikwad , S.D.Mankar , ...
More related articles
Emerging Technologies: Application Of Artificial Intelligence and Machine Learni...
Atharva Dumbre , Saurabh Dushing , Shejal Dongare , Sanjana Gadekar, Rina Gaikwad , S.D.Mankar , ...
Menstrual health: An Herbal Tea Approach...
Dr. Shivam Lale, Vaishnavi Muthal, Harshal Shewale, Nikita Nagare, Dr. Shivam Lale, Dr. M. R. N. Sha...
Ashwagandha (Withania somnifera), Taxonomy, Pharmacological Properties and Its R...
Yash Srivastav , Samsher Bahadur Bind, Aditya Srivastav, ...
Emerging Technologies: Application Of Artificial Intelligence and Machine Learni...
Atharva Dumbre , Saurabh Dushing , Shejal Dongare , Sanjana Gadekar, Rina Gaikwad , S.D.Mankar , ...
Menstrual health: An Herbal Tea Approach...
Dr. Shivam Lale, Vaishnavi Muthal, Harshal Shewale, Nikita Nagare, Dr. Shivam Lale, Dr. M. R. N. Sha...
Ashwagandha (Withania somnifera), Taxonomy, Pharmacological Properties and Its R...
Yash Srivastav , Samsher Bahadur Bind, Aditya Srivastav, ...